Skip to main content
Premium Trial:

Request an Annual Quote

CapitalBio Becomes Roche NimbleGen Service Provider

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CapitalBio has been certified under the Roche NimbleGen Certified Service Provider program, Roche NimbleGen said today.

Under the program, CapitalBio has been certified to process customer samples for Roche NimbleGen's gene expression, comparative genomic hybridization and copy number variation, and DNA methylation services in CapitalBio's Beijing lab.

CapitalBio also has become the first NimbleGen CSP in Asia to implement the MS 200 Microarray Scanner in its array workflow, Roche said.

Headquartered in Beijing, CapitalBio develops and markets diagnostic chips and microarray instruments and services.

"We will now be able to expand our service to customers through access of the complete NimbleGen Single Color (gene expression) or Dual-Color (CGH/CNV and DNA methylation workflow," CaptialBio VP of Operations Junquan Xu said in a statement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.